发布求助
文献互助 智能选刊 最新文献

Journal of Medical Toxicology最新文献

筛选
英文 中文
Articles You Might Have Missed. 你可能错过的文章。
IF 2.9 4区 医学
Journal of Medical Toxicology Pub Date : 2023-08-04 DOI: 10.1007/s13181-023-00959-x
Christopher P Mitchell, Elizabeth G Shanahan
{"title":"Articles You Might Have Missed.","authors":"Christopher P Mitchell, Elizabeth G Shanahan","doi":"10.1007/s13181-023-00959-x","DOIUrl":"https://doi.org/10.1007/s13181-023-00959-x","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9935113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Poison Centers and Pediatric Environmental Health Specialty Units: Productive Two-Way Partnerships. 毒物中心和儿科环境健康专科：富有成效的双向伙伴关系。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2023-07-01 Epub Date: 2023-03-29 DOI: 10.1007/s13181-023-00942-6
Alan D Woolf, Carl R Baum, Michele Burns
{"title":"Poison Centers and Pediatric Environmental Health Specialty Units: Productive Two-Way Partnerships.","authors":"Alan D Woolf, Carl R Baum, Michele Burns","doi":"10.1007/s13181-023-00942-6","DOIUrl":"10.1007/s13181-023-00942-6","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":"19 3","pages":"241-243"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293540/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9705101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biostatistics and Epidemiology Principles for the Toxicologist: The "Testy" Test Characteristics Part II: Positive Predictive Value and Negative Predictive Value. 毒理学家的生物统计学和流行病学原理：Testy "测试特征第二部分：阳性预测值和阴性预测值。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2023-07-01 Epub Date: 2023-06-14 DOI: 10.1007/s13181-023-00953-3
Christy Williams, Barbara Elena Sahagún, Mark K Su
{"title":"Biostatistics and Epidemiology Principles for the Toxicologist: The \"Testy\" Test Characteristics Part II: Positive Predictive Value and Negative Predictive Value.","authors":"Christy Williams, Barbara Elena Sahagún, Mark K Su","doi":"10.1007/s13181-023-00953-3","DOIUrl":"10.1007/s13181-023-00953-3","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":"19 3","pages":"298-302"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293502/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10065242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Total CroFab and Anavip Antivenom Vial Administration in US Rattlesnake Envenomations: 2019-2021. Total CroFab和Anavip抗蛇毒瓶管理在美国响尾蛇毒液:2019-2021。
IF 2.9 4区 医学
Journal of Medical Toxicology Pub Date : 2023-07-01 DOI: 10.1007/s13181-023-00941-7
Nicklaus Brandehoff, Alicia Dalton, Claire Daugherty, Richard C Dart, Andrew A Monte
{"title":"Total CroFab and Anavip Antivenom Vial Administration in US Rattlesnake Envenomations: 2019-2021.","authors":"Nicklaus Brandehoff,&nbsp;Alicia Dalton,&nbsp;Claire Daugherty,&nbsp;Richard C Dart,&nbsp;Andrew A Monte","doi":"10.1007/s13181-023-00941-7","DOIUrl":"https://doi.org/10.1007/s13181-023-00941-7","url":null,"abstract":"<p><strong>Introduction: </strong>In 2018, Anavip became available for the treatment of rattlesnake envenomations in the USA. No comparisons between the treatment characteristics of patients have been made since Anavip and CroFab have both been widely available. The objective of this study was to compare the number of antivenom vials administered of CroFab and Anavip during the treatment of rattlesnake envenomations in the USA.</p><p><strong>Methods: </strong>This was a secondary analysis of rattlesnake envenomations utilizing the North American Snakebite Registry (NASBR) from 2019 through 2021. Frequencies and proportions were used to summarize demographics and baseline clinical characteristics. The primary outcome was total antivenom vials administered during treatment. Secondary outcomes included the number antivenom administration events, total treatment time, and hospital length of stay.</p><p><strong>Results: </strong>Two hundred ninety-one rattlesnake envenomations were analyzed; most occurred in the Western USA (n = 279, 96 %). One hundred one patients (35%) received only CroFab, 110 (38%) received Anavip only, and 80 (27%) received both products. The median number of vials used was 10 for CroFab, 18 for Anavip, and 20 for both antivenoms. More than one antivenom administration was necessary in thirty-nine (39%) patients that received only CroFab and 76 (69%) patients that received Anavip only. The median total treatment time was 5.5 hours for CroFab, 6.5 for Anavip, and 15.5 hours when both antivenoms were administered. All antivenom groups had a median hospital length of stay of 2 days.</p><p><strong>Conclusions: </strong>Rattlesnake envenomated patients in the Western USA treated with CroFab had fewer antivenom vials and fewer antivenom administrations compared to patients treated with Anavip.</p>","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":"19 3","pages":"248-254"},"PeriodicalIF":2.9,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293487/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9706767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin". 评论“苯妥英处理他克莫司与Nirmatrelvir/Ritonavir (Paxlovid™)的药物相互作用”。
IF 2.9 4区 医学
Journal of Medical Toxicology Pub Date : 2023-07-01 DOI: 10.1007/s13181-023-00936-4
Luciana Mello de Oliveira, Tatiane da Silva Dal Pizzol
{"title":"Comment on \"Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin\".","authors":"Luciana Mello de Oliveira,&nbsp;Tatiane da Silva Dal Pizzol","doi":"10.1007/s13181-023-00936-4","DOIUrl":"https://doi.org/10.1007/s13181-023-00936-4","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":"19 3","pages":"307-308"},"PeriodicalIF":2.9,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054184/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9696998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Keeping Safe and Effective Medications Accessible. 保持安全有效的药物可及性。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2023-07-01 Epub Date: 2023-05-26 DOI: 10.1007/s13181-023-00949-z
Maryann Mazer-Amirshahi, Peggy Ye, Andrew Stolbach
{"title":"Keeping Safe and Effective Medications Accessible.","authors":"Maryann Mazer-Amirshahi, Peggy Ye, Andrew Stolbach","doi":"10.1007/s13181-023-00949-z","DOIUrl":"10.1007/s13181-023-00949-z","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":"19 3","pages":"244-245"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293496/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10064675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmaceutical Purchasing: a Review of the Landscape and Implications for Antidotal Therapies. 药品采购：现状回顾及对解毒疗法的影响。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2023-07-01 Epub Date: 2023-05-30 DOI: 10.1007/s13181-023-00943-5
Andrew Troger, Michele M Burns
{"title":"Pharmaceutical Purchasing: a Review of the Landscape and Implications for Antidotal Therapies.","authors":"Andrew Troger, Michele M Burns","doi":"10.1007/s13181-023-00943-5","DOIUrl":"10.1007/s13181-023-00943-5","url":null,"abstract":"<p><p>The management of the poisoned patient often requires the utilization of uncommonly used pharmaceutical interventions. These interventions can be associated with significant costs to both the patient and treating institution. Pharmaceutical supply shortages and issues with accessibility of antidotal therapies complicate the management of many toxic exposures. These challenges are an inherent property of the pharmaceutical purchasing infrastructure in the United States, which is a complicated network of public and private intra-institutional agreements. The cost and availability of any given therapy is dependent on the individual contracting agreements between the treating institution, payer, pharmacy benefit manager, manufacturer or wholesaler, and in some cases a specialty pharmacy. Small or remote hospitals may experience greater challenges related to insufficient patient volume to achieve predicable prescribing patterns of rare and expensive medications, necessitating consignment purchasing arrangements. Although pharmaceutical costs are the focus of recent legislative attention, these reforms are not expected to significantly alter the cost or availability of antidotal therapies.</p>","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":"19 3","pages":"262-267"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293135/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9707337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ACMT Position Statement: End the Use of the Term "Excited Delirium". ACMT 立场声明：停止使用 "兴奋性谵妄 "一词。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2023-07-01 Epub Date: 2023-06-22 DOI: 10.1007/s13181-023-00944-4
Andrew I Stolbach, Paul I Dargan, Howard A Greller, Richard J Hamilton, Kelly Johnson-Arbor, Brian Patrick Murray, Daniel Ovakim, Laura Tormoehlen, Lewis S Nelson
{"title":"ACMT Position Statement: End the Use of the Term \"Excited Delirium\".","authors":"Andrew I Stolbach, Paul I Dargan, Howard A Greller, Richard J Hamilton, Kelly Johnson-Arbor, Brian Patrick Murray, Daniel Ovakim, Laura Tormoehlen, Lewis S Nelson","doi":"10.1007/s13181-023-00944-4","DOIUrl":"10.1007/s13181-023-00944-4","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":"19 3","pages":"310-312"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293509/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10070033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rate of Adverse Outcomes During 6-Hour Observation for Asymptomatic Patients with Select Ingestions. 对无症状的特定误食患者进行 6 小时观察期间的不良后果发生率。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2023-07-01 Epub Date: 2023-06-09 DOI: 10.1007/s13181-023-00954-2
Michael Keenan, Stephen Rice, Emma Frawley, Chelsie Jacques, Susan Wojcik, Jeanna Marraffa
{"title":"Rate of Adverse Outcomes During 6-Hour Observation for Asymptomatic Patients with Select Ingestions.","authors":"Michael Keenan, Stephen Rice, Emma Frawley, Chelsie Jacques, Susan Wojcik, Jeanna Marraffa","doi":"10.1007/s13181-023-00954-2","DOIUrl":"10.1007/s13181-023-00954-2","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":"19 3","pages":"288-292"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9762354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rivastigmine Use in the Treatment of Antimuscarinic Delirium. 使用利凡斯的明治疗抗心律失常谵妄。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2023-07-01 Epub Date: 2023-05-19 DOI: 10.1007/s13181-023-00947-1
Spencer C Greene
{"title":"Rivastigmine Use in the Treatment of Antimuscarinic Delirium.","authors":"Spencer C Greene","doi":"10.1007/s13181-023-00947-1","DOIUrl":"10.1007/s13181-023-00947-1","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":"19 3","pages":"284-287"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293131/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10083271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信